Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.73 |
| ▸ | HTT | P42858 | 1/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.73 |
| ▸ | NPC1 | O15118 | 2/20 | 0.65 |
| ▸ | RAB9A | P51151 | 2/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.65 |
| ▸ | GSK3B | P49841 | 1/20 | 0.63 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.63 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.63 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.63 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.63 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.63 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.63 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.63 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.63 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.63 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.63 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.63 |
| ▸ | POLB | P06746 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7168347 | 0.93 | MAPT (0.71) | MAPTALDH1A1HTTHSD17B10NPC1 | |
| SCHEMBL31357494 | 0.93 | MAPT (0.70) | MAPTALDH1A1HTTHSD17B10NPC1 | |
| SCHEMBL29007321 | 0.91 | MAPT (0.64) | MAPTALDH1A1HTTHSD17B10NPC1 | |
| SCHEMBL6318784 | 0.91 | MAPT (0.64) | MAPTALDH1A1HTTHSD17B10NPC1 | |
| SCHEMBL29207098 | 0.91 | MAPT (0.64) | MAPTALDH1A1HTTHSD17B10NPC1 | |
| SCHEMBL6328277 | 0.91 | MAPT (0.64) | MAPTALDH1A1HTTHSD17B10NPC1 | |
| SCHEMBL6321338 | 0.91 | MAPT (0.64) | MAPTALDH1A1HTTHSD17B10NPC1 | |
| SCHEMBL1144017 | 0.91 | MAPT (0.64) | MAPTALDH1A1HTTHSD17B10NPC1 | |
| SCHEMBL11488970 | 0.91 | MAPT (0.64) | MAPTALDH1A1HTTHSD17B10NPC1 | |
| SCHEMBL26083583 | 0.91 | MAPT (0.64) | MAPTALDH1A1HTTHSD17B10NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119390550-A | Method for catalytically cracking beta-O-4 lignin model compound by using visible light | 浙江工业大学 | 2025-02-07 | — | — | CN | disclosed |
| US-20230339854-A1 | Negative Allosteric Modulation of GluN3-Containing N-Methyl-D-Aspartate Receptors | UNIV EMORY (US) | 2023-10-26 | — | — | US | disclosed |
| US-20230339854-A1 | Negative Allosteric Modulation of GluN3-Containing N-Methyl-D-Aspartate Receptors | UNIV EMORY (US) | 2023-10-26 | — | — | US | disclosed |
| US-10330266-B2 | LED with thermo-responsive black-body line dimming | SIGNIFY HOLDING B.V. (NL) | 2019-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230339854-A1 | Negative Allosteric Modulation of GluN3-Containing N-Methyl-D-Aspartate Receptors | GRIN3A, GRIN3B, GRIN1 | MAPT 1473/4885ALDH1A1 3826/4885HTT 1562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.